{
  "@context": "http://id.who.int/icd/contexts/contextForLinearizationEntity.json",
  "@id": "http://id.who.int/icd/release/11/2024-01/mms/757747508",
  "parent": [
    "http://id.who.int/icd/release/11/2024-01/mms/1762461746"
  ],
  "browserUrl": "https://icd.who.int/browse/2024-01/mms/en#757747508",
  "code": "3B65",
  "source": "http://id.who.int/icd/entity/757747508",
  "classKind": "category",
  "foundationChildElsewhere": [
    {
      "label": {
        "@language": "en",
        "@value": "Thrombotic thrombocytopenic purpura"
      },
      "foundationReference": "http://id.who.int/icd/entity/1708277768",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1708277768"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Haemolytic uraemic syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/630790515",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/630790515"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Methylcobalamin deficiency type cbl G"
      },
      "foundationReference": "http://id.who.int/icd/entity/1948966238",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/67872354"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Hereditary haemolytic uraemic syndrome"
      },
      "foundationReference": "http://id.who.int/icd/entity/1997831581",
      "linearizationReference": "http://id.who.int/icd/release/11/2024-01/mms/1909380523/other"
    }
  ],
  "postcoordinationScale": [
    {
      "@id": "http://id.who.int/icd/release/11/2024-01/mms/757747508/postcoordinationScale/course",
      "axisName": "http://id.who.int/icd/schema/course",
      "requiredPostcoordination": "false",
      "allowMultipleValues": "NotAllowed",
      "scaleEntity": [
        "http://id.who.int/icd/release/11/2024-01/mms/786106375",
        "http://id.who.int/icd/release/11/2024-01/mms/490003542"
      ]
    }
  ],
  "title": {
    "@language": "en",
    "@value": "Thrombotic microangiopathy, not elsewhere classified"
  },
  "definition": {
    "@language": "en",
    "@value": "Thrombotic microangiopathies are microvascular occlusive disorders characterised by systemic or intrarenal aggregation of platelets, thrombocytopenia, and mechanical injury to erythrocytes. Thrombotic thrombocytopenic purpura (TTP) and haemolytic–uremic syndrome (HUS) represent a spectrum of thrombotic microangiopathies. In TTP, systemic microvascular aggregation of platelets causes ischemia in the brain and other organs. In HUS, platelet–fibrin thrombi predominantly occlude the renal circulation."
  },
  "indexTerm": [
    {
      "label": {
        "@language": "en",
        "@value": "Thrombotic microangiopathy, not elsewhere classified"
      }
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acute intravascular thrombotic microangiopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/91655636"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Acute intravascular thrombi microangiopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/91655636"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic intravascular thrombotic microangiopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/764485623"
    },
    {
      "label": {
        "@language": "en",
        "@value": "Chronic intravascular thrombi microangiopathy"
      },
      "foundationReference": "http://id.who.int/icd/entity/764485623"
    }
  ]
}